Evidence map›Paper›PMID 34267268›Full record

SynthesisScientific reports2021

The association between environmental exposures to chlordanes, adiposity and diabetes-related features: a systematic review and meta-analysis.

Vânia Mendes, Cláudia Ribeiro, Inês Delgado, Bárbara Peleteiro, Martine Aggerbeck, Emilie Distel, Isabella Annesi-Maesano, Denis Sarigiannis, Elisabete Ramos

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Endocrine disrupting chemicals and obesity prevention: scoping review.Journal of health, population, and nutrition · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Vânia Mendes *ISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal.
Cláudia Ribeiro *ISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal.
Inês DelgadoISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal.
Bárbara PeleteiroISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal.
Martine AggerbeckINSERM UMR-S 1124, 45 rue des Saints Pères, 75006, Paris, France.
Emilie DistelINSERM UMR-S 1124, 45 rue des Saints Pères, 75006, Paris, France.
Isabella Annesi-MaesanoSorbonne Université and INSERM, Epidemiology of Allergic and Respiratory Diseases Department (EPAR), Pierre Louis Institute of Epidemiology and Public Health (IPLESP UMRS 1136), Saint-Antoine Medical School, Paris, France.
Denis SarigiannisDepartment of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.
Elisabete RamosISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal. eliramos@med.up.pt.
Faculdade de Medicina do ABC · BRToxicologie, Pharmacologie et Signalisation Cellulaire · FRAristotle University of Thessaloniki · GRInserm · FRUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlordane compounds (CHLs) are components of technical chlordane listed in the Stockholm convention on persistent organic pollutants identified as endocrine disrupting chemicals (EDCs) and may interfere with hormone biosynthesis, metabolism or action resulting in an unbalanced hormonal function. There is increasing scientific evidence showing EDCs as risk factors in the pathogenesis and development of obesity and obesity-related metabolic syndromes such as type 2 diabetes, but there is no systematized information on the effect of CHLs in humans. Our aim is to identify the epidemiological data on the association between CHLs with adiposity and diabetes using a systematic approach to identify the available data and summarizing the results through meta-analysis. We searched PubMed and Web of Science from inception up to 15 February 2021, to retrieve original data on the association between chlordanes, and adiposity or diabetes. For adiposity, regression coefficients and Pearson or Spearman correlation coefficients were extracted and converted into standardized regression coefficients. Data were combined using fixed effects meta-analyses to compute summary regression coefficients and corresponding 95% confidence intervals (95% CI). For the association between chlordanes and diabetes, Odds ratios (ORs) were extracted and the DerSimonian and Laird method was used to compute summary estimates and respective 95% CI. For both, adjusted estimates were preferred, whenever available. Among 31 eligible studies, mostly using a cross-sectional approach, the meta-analysis for adiposity was possible only for oxychlordane and transchlordane, none of them were significantly associated with adiposity [(β = 0.04, 95% CI 0.00; 0.07, I

Indexed as

AdiposityChlordanDiabetes MellitusDiabetes Mellitus, Type 2Endocrine DisruptorsEnvironmental ExposureHeptachlor EpoxideHumansHydrocarbons, ChlorinatedRisk FactorsChlordanEndocrine DisruptorsHeptachlor EpoxideHydrocarbons, Chlorinatednonachloroxychlordane

Identifiers

PMID34267268
PMCPMC8282629
OpenAlexW3180951235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.